Lysosomal dysfunction in Down syndrome and Alzheimer mouse models is caused by v-ATPase inhibition by Tyr 682 -phosphorylated APP βCTF
Open accessPublished version of a preprint
The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Abstract
Lysosome dysfunction arises early and propels Alzheimer’s disease (AD). Herein, we show that amyloid precursor protein (APP), linked to early-onset AD in Down syndrome (DS), acts directly via its β-C-terminal fragment (βCTF) to disrupt lysosomal vacuolar (H + )–adenosine triphosphatase (v-ATPase) and acidification. In human DS fibroblasts, the phosphorylated 682 YENPTY internalization motif of APP-βCTF binds selectively within a pocket of the v-ATPase V0a1 subunit cytoplasmic domain and competitively inhibits association of the V1 subcomplex of v-ATPase, thereby reducing its activity. Lowering APP-βCTF Tyr 682 phosphorylation restores v-ATPase and lysosome function in DS fibroblasts and in vivo in brains of DS model mice. Notably, lowering APP-βCTF Tyr 682 phosphorylation below normal constitutive levels boosts v-ATPase assembly and activity, suggesting that v-ATPase may also be modulated tonically by phospho-APP-βCTF. Elevated APP-βCTF Tyr 682 phosphorylation in two mouse AD models similarly disrupts v-ATPase function. These findings offer previously unknown insight into the pathogenic mechanism underlying faulty lysosomes in all forms of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






![Fig. 7. Defective lysosomal v-ATPase function in Ts2 mouse model and human DS brain. (A and B) Representative fluorescence images of tfLC3 color changes of TRGL or Ts2xTRGL adult brain (A) and respective quantification of puncta representing ALs (fully or less acidified) (B). For data analysis, color change of tfLC3-positive vesicles was calculated with CTSD colabeling. Bar colors denote the colors of puncta; purple bars indicate tfLC3 with CTSD (fully acidified ALs, quenched eGFP), and white bars indicate tfLC3 with CTSD (less acidified ALs, unquenched eGFP) (n = 504 neurons, 6 TRGL mice; n = 537 neurons, 6 Ts2xTRGL mice). (C) ATP hydrolysis activity of v-ATPase was measured using Lyso fraction (15 to 18) of the iodixanol step gradient from adult mice (n = 5, triplicate). (D) Adult mouse brain from control (2N) and Ts2 homogenates were fractionated through an iodixanol step gradient. Each fraction [lysosomal enriched fraction (Lyso): 15 to 18; exclude lysosomal enriched fraction (Lyso−): 1 to 14 and 19 to 22] and post-nuclear supernatant (PNS) were resolved using the SDS-PAGE and immunoblotted with anti-V1A, anti-V1C1, anti-V1D, anti-V0a1, and anti-V0d1 antibodies. (E) The graphs represent levels of v-ATPase subunits from each fraction (n = 4). (F and H) Membrane fractions from mouse brain (F) or frozen human brain tissue (H) were resolved using the native. (G and I) The graph represents relative ratio of full complex divided by total (full plus partial complexes) complexes of v-ATPase (n = 5). Quantitative data (B, C, E, G, and I) are presented as mean values with ±SEM, two-tailed unpaired t test (C, G, and I) and ordinary one-way ANOVA with Šidák’s multiple comparisons test (B and E). Each dot corresponds to average value of technical replicates from one mouse.](https://figures.cochat.ai/paper-figures/95ff4b22fb924cf88f0d3de12fcbf900/lysosomal-dysfunction-in-down-syndrome-and-alzheimer-mouse-models-is-caused-by-v-figure-7.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“For instance, increased phosphorylation of APP β-C-terminal fragment (βCTF) Tyr682 inhibited the assembly and activity of V-ATPase by binding to the V0a1 subunit, resulting in elevated lysosomal pH and impaired degradation capacity.271”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [271]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Poulsen, E. T., Iannuzzi, F., Rasmussen, H. F., Maier, T. J., Enghild, J. J., Jørgensen, A. L., & Matrone, C. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00059 · Cited by 33
RetractedRepertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
The Amber biomolecular simulation programs
Case, D. A., Cheatham, T. E., Darden, T., Gohlke, H., Luo, R., Merz, K. M., Onufriev, A., Simmerling, C., Wang, B., & Woods, R. J. (2005) · Journal of Computational Chemistry · doi:10.1002/jcc.20290 · Cited by 9,535
Cui, C., Cui, J., Jin, F., Cui, Y., Li, R., Jiang, X., Tian, Y., Wang, K., Jiang, P., & Gao, J. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479571 · Cited by 5,203
Halgren, T. A., Murphy, R. B., Friesner, R. A., Beard, H. S., Frye, L. L., Pollard, W. T., & Banks, J. L. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030644s · Cited by 5,177
Rappsilber, J., Mann, M., & Ishihama, Y. (2007) · Nature Protocols · doi:10.1038/nprot.2007.261 · Cited by 4,641
Autophagy regulates lipid metabolism
Singh, R., Kaushik, S., Wang, Y., Xiang, Y., Novak, I., Komatsu, M., Tanaka, K., Cuervo, A. M., & Czaja, M. J. (2009) · Nature · doi:10.1038/nature07976 · Cited by 3,975
Knopman, D. S., Amieva, H., Petersen, R. C., Chételat, G., Holtzman, D. M., Hyman, B. T., Nixon, R. A., & Jones, D. T. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00269-y · Cited by 2,606
Self-citationDirect observation of individual endogenous protein complexes in situ by proximity ligation
Söderberg, O., Gullberg, M., Jarvius, M., Ridderstråle, K., Leuchowius, K.-J., Jarvius, J., Wester, K., Hydbring, P., Bahram, F., Larsson, L.-G., et al. (2006) · Nature Methods · doi:10.1038/nmeth947 · Cited by 2,419
The role of autophagy in neurodegenerative disease
Nixon, R. A. (2013) · Nature Medicine · doi:10.1038/nm.3232 · Cited by 2,059
Self-citationZoncu, R., Bar-Peled, L., Efeyan, A., Wang, S., Sancak, Y., & Sabatini, D. M. (2011) · Science · doi:10.1126/science.1207056 · Cited by 1,673
Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology
Forgac, M. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2272 · Cited by 1,619
Lysosomes as dynamic regulators of cell and organismal homeostasis
Ballabio, A., & Bonifacino, J. S. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0185-4 · Cited by 1,469
Lysosomal acidification mechanisms
Mindell, J. A. (2012) · Annual Review of Physiology · doi:10.1146/annurev-physiol-012110-142317 · Cited by 1,258
Lee, J.-H., Yu, W. H., Kumar, A., Lee, S., Mohan, P. S., Peterhoff, C. M., Wolfe, D. M., Martinez-Vicente, M., Massey, A. C., Sovak, G., et al. (2010) · Cell · doi:10.1016/j.cell.2010.05.008 · Cited by 1,212
Self-citationTheory and applications of the generalized born solvation model in macromolecular simulations
Tsui, V., & Case, D. A. (2000) · Biopolymers · doi:10.1002/1097-0282(2000)56:4<275::aid-bip10024>3.0.co;2-e · Cited by 977
Autophagy, amyloidogenesis and Alzheimer disease
Nixon, R. A. (2007) · Journal of Cell Science · doi:10.1242/jcs.019265 · Cited by 749
Self-citationElevated β-secretase expression and enzymatic activity detected in sporadic Alzheimer disease
Yang, L.-B., Lindholm, K., Yan, R., Citron, M., Xia, W., Yang, X.-L., Beach, T., Sue, L., Wong, P., Price, D., et al. (2003) · Nature Medicine · doi:10.1038/nm0103-3 · Cited by 729
Lee, J.-H., Yang, D.-S., Goulbourne, C. N., Im, E., Stavrides, P., Pensalfini, A., Chan, H., Bouchet-Marquis, C., Bleiwas, C., Berg, M. J., et al. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01084-8 · Cited by 638 · cited 2×
“, (26, 59) Rabbit anti-Rab5 Abcam Cat# ab218624; RRID: AB_2892717 Mouse anti-Rab7 Abcam Cat# ab50533; RRID: AB_882241 Mouse anti-PDI GeneTex Cat# GTX22792; RRID: AB_384853 Rabbit anti-Syntaxin 6 Cell Signaling Technology Cat# 2869; RRID: AB_2196500 Mouse anti-Tubulin Sigma-Aldrich Cat# T8535; RRID: AB_261795 Mouse ant…”
ResultSelf-citationTau fragmentation, aggregation and clearance: the dual role of lysosomal processing
Wang, Y., Martinez-Vicente, M., Krüger, U., Kaushik, S., Wong, E., Mandelkow, E.-M., Cuervo, A. M., & Mandelkow, E. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp367 · Cited by 617
Autophagy failure in Alzheimer's disease—locating the primary defect
Nixon, R. A., & Yang, D.-S. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.01.021 · Cited by 595
Self-citationPromoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing
Boland, B., Yu, W. H., Corti, O., Mollereau, B., Henriques, A., Bezard, E., Pastores, G. M., Rubinsztein, D. C., Nixon, R. A., Duchen, M. R., et al. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.109 · Cited by 558
Self-citationColacurcio, D. J., & Nixon, R. A. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.05.004 · Cited by 548
Self-citationSalehi, A., Delcroix, J.-D., Belichenko, P. V., Zhan, K., Wu, C., Valletta, J. S., Takimoto-Kimura, R., Kleschevnikov, A. M., Sambamurti, K., Chung, P. P., et al. (2006) · Neuron · doi:10.1016/j.neuron.2006.05.022 · Cited by 543
Self-citationNixon, R. A. (2017) · The FASEB Journal · doi:10.1096/fj.201700359 · Cited by 400
Self-citationCataldo, A. M., Barnett, J. L., Pieroni, C., & Nixon, R. A. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-16-06142.1997 · Cited by 393
Self-citationDementia in Down syndrome: unique insights for Alzheimer disease research
Lott, I. T., & Head, E. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-018-0132-6 · Cited by 383
Neurodegenerative lysosomal disorders: A continuum from development to late age
Nixon, R. A., Yang, D.-S., & Lee, J.-H. (2008) · Autophagy · doi:10.4161/auto.6259 · Cited by 362
Self-citationCataldo, A., Hamilton, D., Barnett, J., Paskevich, P., & Nixon, R. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-01-00186.1996 · Cited by 359
Self-citationLee, J.-H., McBrayer, M. K., Wolfe, D. M., Haslett, L. J., Kumar, A., Sato, Y., Lie, P. P. Y., Mohan, P., Coffey, E. E., Kompella, U., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.07.050 · Cited by 358
Self-citationDe Strooper, B. (2007) · EMBO reports · doi:10.1038/sj.embor.7400897 · Cited by 351
Induction of autophagy by amino-acid deprivation in perfused rat liver
MORTIMORE, G. E., & SCHWORER, C. M. (1977) · Nature · doi:10.1038/270174a0 · Cited by 341
Recent Insights into the Structure, Regulation, and Function of the V-ATPases
Cotter, K., Stransky, L., McGuire, C., & Forgac, M. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.08.005 · Cited by 337
Molecular dynamics simulation of nucleic acids: Successes, limitations, and promise
Cheatham, T. E., & Young, M. A. (2000) · Biopolymers · doi:10.1002/1097-0282(2000)56:4<232::aid-bip10037>3.0.co;2-h · Cited by 336
Fyn inhibition rescues established memory and synapse loss in Alzheimer mice
Kaufman, A. C., Salazar, S. V., Haas, L. T., Yang, J., Kostylev, M. A., Jeng, A. T., Robinson, S. A., Gunther, E. C., van Dyck, C. H., Nygaard, H. B., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24394 · Cited by 314
Jiang, Y., Mullaney, K. A., Peterhoff, C. M., Che, S., Schmidt, S. D., Boyer-Boiteau, A., Ginsberg, S. D., Cataldo, A. M., Mathews, P. M., & Nixon, R. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908953107 · Cited by 292
Self-citationFemales exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model
Hirata-Fukae, C., Li, H.-F., Hoe, H.-S., Gray, A. J., Minami, S. S., Hamada, K., Niikura, T., Hua, F., Tsukagoshi-Nagai, H., Horikoshi-Sakuraba, Y., et al. (2008) · Brain Research · doi:10.1016/j.brainres.2008.03.079 · Cited by 284
Electron cryomicroscopy observation of rotational states in a eukaryotic V-ATPase
Zhao, J., Benlekbir, S., & Rubinstein, J. L. (2015) · Nature · doi:10.1038/nature14365 · Cited by 283
Lysosome trafficking and signaling in health and neurodegenerative diseases
Lie, P. P. Y., & Nixon, R. A. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.05.015 · Cited by 269
Self-citationDistinct mechanisms of ferritin delivery to lysosomes in iron-depleted and iron-replete cells
Asano, T., Komatsu, M., Yamaguchi-Iwai, Y., Ishikawa, F., Mizushima, N., & Iwai, K. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01437-10 · Cited by 265
Ando, K., Iijima, K.-I., Elliott, J. I., Kirino, Y., & Suzuki, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104059200 · Cited by 261
Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer’s Disease: The Role of APP
Doran, E., Keator, D., Head, E., Phelan, M. J., Kim, R., Totoiu, M., Barrio, J. R., Small, G. W., Potkin, S. G., & Lott, I. T. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160836 · Cited by 244
Cataldo, A. M., Petanceska, S., Peterhoff, C. M., Terio, N. B., Epstein, C. J., Villar, A., Carlson, E. J., Staufenbiel, M., & Nixon, R. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-17-06788.2003 · Cited by 241
Self-citationStructure of V-ATPase from the mammalian brain
Abbas, Y. M., Wu, D., Bueler, S. A., Robinson, C. V., & Rubinstein, J. L. (2020) · Science · doi:10.1126/science.aaz2924 · Cited by 233
De Jonghe, C. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.16.1665 · Cited by 223
Lysosomal pathways to cell death and their therapeutic applications
Hafner Česen, M., Pegan, K., Špes, A., & Turk, B. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.03.005 · Cited by 222
Lauritzen, I., Pardossi-Piquard, R., Bourgeois, A., Pagnotta, S., Biferi, M.-G., Barkats, M., Lacor, P., Klein, W., Bauer, C., & Checler, F. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1577-6 · Cited by 219
Kim, S., Sato, Y., Mohan, P. S., Peterhoff, C., Pensalfini, A., Rigoglioso, A., Jiang, Y., & Nixon, R. A. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.97 · Cited by 212
Self-citationDiwu, Z., Chen, C.-S., Zhang, C., Klaubert, D. H., & Haugland, R. P. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(99)80059-3 · Cited by 212
Down Syndrome Fibroblast Model of Alzheimer-Related Endosome Pathology
Cataldo, A. M., Mathews, P. M., Boiteau, A. B., Hassinger, L. C., Peterhoff, C. M., Jiang, Y., Mullaney, K., Neve, R. L., Gruenberg, J., & Nixon, R. A. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.071053 · Cited by 186
Self-citationOxidative Stress and Down Syndrome: A Route toward Alzheimer-Like Dementia
Perluigi, M., & Butterfield, D. A. (2012) · Current Gerontology and Geriatrics Research · doi:10.1155/2012/724904 · Cited by 181
Autophagy and Neuronal Cell Death in Neurological Disorders
Nixon, R. A., & Yang, D.-S. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008839 · Cited by 181
Self-citationHoey, S. E., Williams, R. J., & Perkinton, M. S. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.6017-08.2009 · Cited by 178
Structures of a Complete Human V-ATPase Reveal Mechanisms of Its Assembly
Wang, L., Wu, D., Robinson, C. V., Wu, H., & Fu, T.-M. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.09.029 · Cited by 168
Colacurcio, D. J., Pensalfini, A., Jiang, Y., & Nixon, R. A. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.10.001 · Cited by 167
Self-citationLysosomal Dysfunction in Down Syndrome Is APP-Dependent and Mediated by APP-βCTF (C99)
Jiang, Y., Sato, Y., Im, E., Berg, M., Bordi, M., Darji, S., Kumar, A., Mohan, P. S., Bandyopadhyay, U., Diaz, A., et al. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.0578-19.2019 · Cited by 166 · cited 1×
“*Results from this study and our previous studies (see references in parentheses) N/A: not applicable Model system Human Mouse DS Ts2 5xFAD or Tg2576 fibroblast Cortical neuronal culture Cortical Neuron In situ Cortical Neuron In situ Lysosomal pH (5) (26) Lysosomal enzymatic activity ̄ (5) ̄ (5) N/A N/A Lysos…”
ResultSelf-citationKlein, Z. A., Takahashi, H., Ma, M., Stagi, M., Zhou, M., Lam, T. T., & Strittmatter, S. M. (2017) · Neuron · doi:10.1016/j.neuron.2017.06.026 · Cited by 165
Cataldo, A. M., Peterhoff, C. M., Schmidt, S. D., Terio, N. B., Duff, K., Beard, M., Mathews, P. M., & Nixon, R. A. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.8.821 · Cited by 157
Self-citationBagh, M. B., Peng, S., Chandra, G., Zhang, Z., Singh, S. P., Pattabiraman, N., Liu, A., & Mukherjee, A. B. (2017) · Nature Communications · doi:10.1038/ncomms14612 · Cited by 157
The aging lysosome: An essential catalyst for late-onset neurodegenerative diseases
Nixon, R. A. (2020) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2020.140443 · Cited by 149
Self-citationTamayev, R., Matsuda, S., Arancio, O., & D'Adamio, L. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100195 · Cited by 142
Amino Acid Availability Modulates Vacuolar H+-ATPase Assembly
Stransky, L. A., & Forgac, M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.659128 · Cited by 141
Nakamura, N., Matsuura, A., Wada, Y., & Ohsumi, Y. (1997) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021592 · Cited by 140
LRRK2 interacts with the vacuolar-type H+-ATPase pump a1 subunit to regulate lysosomal function
Wallings, R. L., Connor‐Robson, N., & Wade‐Martins, R. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz088 · Cited by 121
Zambrano, N., Bruni, P., Minopoli, G., Mosca, R., Molino, D., Russo, C., Schettini, G., Sudol, M., & Russo, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100792200 · Cited by 117
Distinct patterns of APP processing in the CNS in autosomal-dominant and sporadic Alzheimer disease.
Pera, M., Alcolea, D., Sánchez-Valle, R., Guardia-Laguarta, C., Colom-Cadena, M., Badiola, N., Suárez-Calvet, M., Lladó, A., Barrera-Ocampo, A. A., Sepulveda-Falla, D., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-012-1062-9 · Cited by 115
Butterfield, D. A., Di Domenico, F., Swomley, A. M., Head, E., & Perluigi, M. (2014) · Biochemical Journal · doi:10.1042/bj20140772 · Cited by 113
Villar, A. J., Belichenko, P. V., Gillespie, A. M., Kozy, H. M., Mobley, W. C., & Epstein, C. J. (2005) · Mammalian Genome · doi:10.1007/s00335-004-2428-7 · Cited by 105
Woodruff, G., Reyna, S. M., Dunlap, M., Van Der Kant, R., Callender, J. A., Young, J. E., Roberts, E. A., & Goldstein, L. S. B. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.034 · Cited by 105
Calpain Activity Regulates the Cell Surface Distribution of Amyloid Precursor Protein
Mathews, P. M., Jiang, Y., Schmidt, S. D., Grbovic, O. M., Mercken, M., & Nixon, R. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205208200 · Cited by 104
Self-citationTMEM9 promotes intestinal tumorigenesis through vacuolar-ATPase-activated Wnt/β-catenin signalling
Jung, Y., Jun, S., Kim, M. J., Lee, S. H., Suh, H. N., Lien, E. M., Jung, H., Lee, S., Zhang, J., Yang, J., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0219-8 · Cited by 104
Structural requirements of procathepsin D activation and maturation.
Richo, G. R., & Conner, G. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36696-6 · Cited by 97
Ho, G. J., Hashimoto, M., Adame, A., Izu, M., Alford, M. F., Thal, L. J., Hansen, L. A., & Masliah, E. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.06.016 · Cited by 97
Jiang, Y., Rigoglioso, A., Peterhoff, C. M., Pawlik, M., Sato, Y., Bleiwas, C., Stavrides, P., Smiley, J. F., Ginsberg, S. D., Mathews, P. M., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.11.013 · Cited by 97
Self-citationLie, P. P. Y., Yang, D.-S., Stavrides, P., Goulbourne, C. N., Zheng, P., Mohan, P. S., Cataldo, A. M., & Nixon, R. A. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109034 · Cited by 97
Self-citationRegulation of V-ATPase activity
Forgac, M. D. (2016) · Frontiers in bioscience · doi:10.2741/4506 · Cited by 91
Structure of the intracellular domain of the amyloid precursor protein in complex with Fe65‐PTB2
Radzimanowski, J., Simon, B., Sattler, M., Beyreuther, K., Sinning, I., & Wild, K. (2008) · EMBO reports · doi:10.1038/embor.2008.188 · Cited by 86
Lee, J., Rao, M. V., Yang, D., Stavrides, P. H., Im, E., Pensalfini, A., Huo, C., Sarkar, P., Yoshimori, T., & Nixon, R. A. (2018) · Autophagy · doi:10.1080/15548627.2018.1528812 · Cited by 85
Self-citationLiberman, R. N., Bond, S., Shainheit, M. G., Stadecker, M. J., & Forgac, M. D. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.524561 · Cited by 77
Russo, C., Salis, S., Dolcini, V., Venezia, V., Song, X., Teller, J. K., & Schettini, G. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0357 · Cited by 75
Upregulation of RIN3 induces endosomal dysfunction in Alzheimer’s disease
Shen, R., Zhao, X., He, L., Ding, Y., Xu, W., Lin, S., Fang, S., Yang, W., Sung, K., Spencer, B., et al. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-00206-1 · Cited by 75
Prete, D. D., Lombino, F. L., Liu, X., & D'adamio, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108576 · Cited by 72
Zinc efflux through lysosomal exocytosis prevents zinc-induced toxicity
Kukic, I., Kelleher, S. L., & Kiselyov, K. (2014) · Journal of Cell Science · doi:10.1242/jcs.145318 · Cited by 67
Lie, P. P. Y., Yoo, L., Goulbourne, C. N., Berg, M. J., Stavrides, P., Huo, C., Lee, J.-H., & Nixon, R. A. (2022) · Science Advances · doi:10.1126/sciadv.abj5716 · Cited by 63
Self-citationIs γ-secretase a beneficial inactivating enzyme of the toxic APP C-terminal fragment C99?
Checler, F., Afram, E., Pardossi-Piquard, R., & Lauritzen, I. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100489 · Cited by 59
Hwang, J., Estick, C., Ikonne, U. S., Butler, D., Pait, M. C., Elliott, L. H., Ruiz, S., Smith, K., Rentschler, K. M., Mundell, C. T., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184432 · Cited by 58
Caspase-8 Induces Lysosome-Associated Cell Death in Cancer Cells
Zhong, B., Liu, M., Bai, C., Ruan, Y., Wang, Y., Qiu, L., Hong, Y., Wang, X., Li, L., & Li, B. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.01.022 · Cited by 51
Fyn Modulation of Dab1 Effects on Amyloid Precursor Protein and ApoE Receptor 2 Processing
Hoe, H.-S., Minami, S. S., Makarova, A., Lee, J., Hyman, B. T., Matsuoka, Y., & Rebeck, G. W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m704140200 · Cited by 49
Self-citationZuliani, G., Trentini, A., Rosta, V., Guerrini, R., Pacifico, S., Bonazzi, S., Guiotto, A., Passaro, A., Seripa, D., Valacchi, G., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-72168-3 · Cited by 46
TARR, P. E., Contursi, C., Roncarati, R., Noviello, C., Ghersi, E., Scheinfeld, M. H., Zambrano, N., Russo, T., & D'adamio, L. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00678-2 · Cited by 45
Lee, J., Wolfe, D. M., Darji, S., McBrayer, M. K., Colacurcio, D. J., Kumar, A. R., Stavrides, P. H., Mohan, P. S., & Nixon, R. A. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.02.021 · Cited by 43
Self-citationWalker, M. W., & Lloyd‐Evans, E. (2015) · Methods in cell biology · doi:10.1016/bs.mcb.2014.10.019 · Cited by 40
The convergence of endosomal and autophagosomal pathways: Implications for APP-CTF degradation
Tian, Y., Chang, J. C., Greengard, P., & Flajolet, M. (2014) · Autophagy · doi:10.4161/auto.27802 · Cited by 39
Endosomal-lysosomal dysfunction in metabolic diseases and Alzheimer's disease
(2020) · International Review of Neurobiology · doi:10.1016/bs.irn.2020.02.012 · Cited by 38
Iannuzzi, F., Sirabella, R., Canu, N., Maier, T. J., Annunziato, L., & Matrone, C. (2020) · Cells · doi:10.3390/cells9081807 · Cited by 36
Relevance of transgenic mouse models for Alzheimer's disease
(2021) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2020.07.007 · Cited by 35
Wang, Z., Zhang, Q., Lin, J.-R., Jabalameli, M. R., Mitra, J., Nguyen, N., & Zhang, Z. D. (2021) · Scientific Reports · doi:10.1038/s41598-021-99352-3 · Cited by 30
Functional Implications of the Conformational Switch in AICD Peptide upon Binding to Grb2-SH2 Domain
Das, S., Raychaudhuri, M., Sen, U., & Mukhopadhyay, D. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.09.046 · Cited by 24
Yañez, M. J., Belbin, O., Estrada, L. D., Leal, N. R., Contreras, P. S., Lleó, A., Burgos, P. V., Zanlungo, S., & Alvarez, A. R. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.08.016 · Cited by 24
Tam, J. H. K., Cobb, M. R., Seah, C., & Pasternak, S. H. (2016) · PLOS ONE · doi:10.1371/journal.pone.0161445 · Cited by 24
Nucleolipid Acid-Based Nanocarriers Restore Neuronal Lysosomal Acidification Defects
Brouillard, M., Barthélémy, P., Dehay, B., Crauste–Manciet, S., & Desvergnes, V. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.736554 · Cited by 19
Cited by
Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138
Mechanisms of autophagy–lysosome dysfunction in neurodegenerative diseases
Nixon, R. A., & Rubinsztein, D. C. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00757-5 · Cited by 435
Self-citationQuick, J. D., Silva, C., Wong, J. H., Lim, K. L., Reynolds, R., Barron, A. M., Zeng, J., & Lo, C. H. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02866-y · Cited by 203
Lo, C. H., & Zeng, J. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00362-0 · Cited by 117
Mustaly-Kalimi, S., Gallegos, W., Marr, R. A., Gilman-Sachs, A., Peterson, D. A., Sekler, I., & Stutzmann, G. E. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2211999119 · Cited by 55
Metadata
- Authors
- Im, E., Jiang, Y., Stavrides, P. H., Darji, S., Erdjument-Bromage, H., Neubert, T. A., Choi, J. Y., Wegiel, J., Lee, J.-H., & Nixon, R. A.
- Affiliations
- Nathan Kline Institute for Psychiatric Research (US)
- Department of Cell Biology, New York University Grossman School of Medicine, New York, NY 10016, USA.
- New York University (US)
- Queens College, CUNY (US)
- Department of Developmental Neurobiology, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, NY 10314, USA.
- Corresponding author
- Nixon, Ralph A.
- ORCID
- Venue
- Science Advances
- Published
- 2023-07-28
- Volume
- 9
- Issue
- 30
- Pages
- eadg1925-eadg1925
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC10371027
- OpenAlex
- W4385283633
- Cited by
- 80
- References
- 101
- Citations by year
- 2026: 22 · 2025: 30 · 2024: 19 · 2023: 8
- FWCI
- 13.95
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Yonsei University
- National Institutes of Health
- NYU Grossman School of Medicine
- National Institute on Aging (P01AG017617, R01AG062376)
- National Center for Research Resources (S10RR027990)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Calcium signaling and nucleotide metabolism
- Keywords
- lysosomal dysfunction, Down syndrome, Alzheimer's disease, amyloid precursor protein, V-ATPase inhibition, lysosomal acidification, V-ATPase assembly, APP overexpression
- MeSH terms
- Adenosine Triphosphatases, Alzheimer Disease, Animals, Disease Models, Animal, Down Syndrome, Humans, Lysosomes, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.